| cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
| NM_001024947.2 | .a | 1 to 3445 | 1 to 3445 | exact | RefSeq, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 3445/3445 (100 %) | 0 diff (100 %id) | |
| AY640928 | .a | 85 to 2337 | 1 to 2253 | exact | tiling clone, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 2253/2253 (100 %) | 0 diff (100 %id) | |
| AK124065 | synovial membrane tissue from rheumatioidarthritis | .a | 94 to 2337 | 1 to 2246 | G214V | available from FLJ, | 2246/2246 (100 %) | 5 diff (99.8 %id) | |
| DA982018 | synovial membrane tissue from rheumatioidarthritis | .a | 95 to 597 | 2 to 504 | capped | 503/503 (100 %) | 0 diff (100 %id) | ||
| DB043159 | testis | .a | 206 to 777 | 2 to 574 | capped | 573/573 (100 %) | 1 diff (99.9 %id) | ||
| TI_1948090579 | .a | 426 to 755 | 105 to 440 | fully sequenced, | 342/348 (98 %) | 10 diff (97.2 %id) | |||
| TI_1948090678 | .a | 426 to 755 | 110 to 445 | fully sequenced, | 342/349 (97 %) | 9 diff (97.5 %id) | |||
| TI_1948090766 | .a | 426 to 895 | 102 to 577 | fully sequenced, | 482/487 (98 %) | 10 diff (98.0 %id) | |||
| EC446241 | Prostate | .a | 429 to 524 | 1 to 95 | 95/95 (100 %) | 3 diff (96.9 %id) | |||
| DB245604 | uterus, tumor tissue | .a | 434 to 997 | 2 to 565 | capped | 564/564 (100 %) | 0 diff (100 %id) | ||
| CD632796 | .a | 437 to 1173 | 764 to 26 | 739/766 (96 %) | 9 diff (98.9 %id) | ||||
| BG166649 | hypernephroma, cell line, Kidney | .a | 439 to 1094 | 7 to 670 | 662/670 (98 %) | 19 diff (97.2 %id) | |||
| AF140225 | .a | 442 to 1215 | 1 to 774 | A136D F137L G138A I155S I192Y | 774/774 (100 %) | 8 diff (99.0 %id) | |||
| CV026998 | mixed | .a | 442 to 1076 | 1 to 634 | 634/634 (100 %) | 2 diff (99.7 %id) | |||
| CV574764 | cornea, eye | .a | 446 to 1059 | 1 to 614 | 614/614 (100 %) | 0 diff (100 %id) | |||
| TI_1948090500 | .a | 446 to 800 | 133 to 487 | 355/387 (91 %) | 6 diff (98.5 %id) | ||||
| BP380148 | uterus | .a | 455 to 1030 | 1 to 569 | 569/569 (100 %) | 4 diff (99.3 %id) | |||
| AL542272 | placenta | .a | 467 to 1616 | 1 to 1142 | 1142/1143 (99 %) | 30 diff (97.4 %id) | |||
| BQ060846 | lymph, lymphoma, cell line | .a | 467 to 1359 | 29 to 925 | 897/1003 (89 %) | 13 diff (98.8 %id) | |||
| DR159638 | human embryonic stem cells differentiated toan early endodermal cell type | .a | 467 to 1218 | 1 to 752 | 752/752 (100 %) | 0 diff (100 %id) | |||
| CD632792 | .a | 474 to 1052 | 625 to 42 | 584/634 (92 %) | 12 diff (98.2 %id) | ||||
| CD632794 | .a | 479 to 1173 | 731 to 21 | 619/731 (84 %) | 22 diff (97.0 %id) | ||||
| CN423567 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 486 to 1050 | 1 to 565 | 565/565 (100 %) | 0 diff (100 %id) | |||
| BY795473 | eye | .a | 495 to 1113 | 1 to 618 | 618/618 (100 %) | 1 diff (99.9 %id) | |||
| BQ434957 | melanotic melanoma, skin | .a | 506 to 1187 | 1 to 691 | 691/834 (82 %) | 12 diff (98.6 %id) | |||
| BP298337 | .a | 555 to 1132 | 1 to 579 | 579/579 (100 %) | 3 diff (99.5 %id) | ||||
| CB150061 | Liver | .a | 571 to 1244 | 1 to 674 | 674/674 (100 %) | 0 diff (100 %id) | |||
| AW364013 | colon | .a | 596 to 1132 | 11 to 564 | 565/564 (100 %) | 77 diff (86.4 %id) | |||
| BP335559 | coronary artery | .a | 631 to 1214 | 1 to 582 | 582/582 (100 %) | 3 diff (99.5 %id) | |||
| CN423574 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 680 to 1229 | 1 to 550 | 550/550 (100 %) | 1 diff (99.9 %id) | |||
| TI_1948090580 | .a | 694 to 1214 | 647 to 127 | fully sequenced, | 521/647 (80 %) | 0 diff (100 %id) | |||
| TI_1948090679 | .a | 694 to 1214 | 646 to 126 | fully sequenced, | 521/646 (80 %) | 0 diff (100 %id) | |||
| CB143262 | Liver | .a | 738 to 1314 | 1 to 577 | 577/577 (100 %) | 0 diff (100 %id) | |||
| BU199255 | .a | 780 to 1604 | 1 to 830 | 830/913 (90 %) | 44 diff (95.2 %id) | ||||
| BG541795 | lung | .a | 793 to 1391 | 1 to 599 | 599/600 (99 %) | 2 diff (99.7 %id) | |||
| CD632805 | .a | 800 to 1575 | 780 to 1 | 780/780 (100 %) | 11 diff (98.6 %id) | ||||
| BF035681 | adenocarcinoma, ovary | .a | 809 to 1548 | 1 to 713 | 713/911 (78 %) | 38 diff (95.9 %id) | |||
| CN423571 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 839 to 1312 | 1 to 473 | 473/473 (100 %) | 1 diff (99.8 %id) | |||
| CF264676 | Brain glioblastoma | .a | 840 to 1692 | 1 to 864 | 864/879 (98 %) | 16 diff (98.2 %id) | |||
| TI_1948090767 | .a | 840 to 1214 | 500 to 126 | fully sequenced, | 375/500 (75 %) | 0 diff (100 %id) | |||
| AA373289 | lung | .a | 882 to 1294 | 1 to 413 | 413/413 (100 %) | 0 diff (100 %id) | |||
| AL711707 | human skeletal muscle | .a | 897 to 1454 | 1 to 557 | 557/557 (100 %) | 2 diff (99.7 %id) | |||
| BP264733 | umbilical vein | .a | 905 to 1477 | 1 to 573 | 573/573 (100 %) | 2 diff (99.7 %id) | |||
| BP204841 | coronary artery | .a | 948 to 1526 | 1 to 579 | 579/579 (100 %) | 7 diff (98.8 %id) | |||
| BI860915 | breast, mammary adenocarcinoma, cell line | .a | 960 to 1777 | 1 to 818 | 818/820 (99 %) | 11 diff (98.7 %id) | |||
| TI_57192409 | .a | 960 to 1777 | 58 to 875 | 818/820 (99 %) | 11 diff (98.7 %id) | ||||
| CD579753 | brain | .a | 964 to 1594 | 1 to 636 | 636/642 (99 %) | 19 diff (97.1 %id) | |||
| CB130813 | Liver | .a | 967 to 1557 | 1 to 591 | 591/591 (100 %) | 0 diff (100 %id) | |||
| TI_1948090501 | .a | 977 to 1214 | 363 to 126 | 238/265 (89 %) | 0 diff (100 %id) | ||||
| AB014733 | heart | .a | 981 to 3445 | 1 to 2469 | tiling clone, | 2469/2469 (100 %) | 8 diff (99.7 %id) | ||
| CN423565 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 981 to 1537 | 23 to 579 | 557/579 (96 %) | 9 diff (98.5 %id) | |||
| BM009206 | amelanotic melanoma, cell line, skin | .a | 1000 to 1781 | 1 to 785 | 785/785 (100 %) | 7 diff (99.2 %id) | |||
| BM556539 | amelanotic melanoma, cell line, skin | .a | 1001 to 1880 | 1 to 886 | AAA | 886/950 (93 %) | 41 diff (95.7 %id) | ||
| BM913160 | amelanotic melanoma, cell line, skin | .a | 1001 to 1713 | 23 to 738 | 716/1100 (65 %) | 21 diff (98.1 %id) | |||
| BM562472 | amelanotic melanoma, cell line, skin | .a | 1001 to 1905 | 1 to 908 | 908/998 (90 %) | 14 diff (98.6 %id) | |||
| TI_59383925 | .a | 1001 to 1781 | 101 to 884 | 784/784 (100 %) | 6 diff (99.3 %id) | ||||
| CB113077 | Liver | .a | 1003 to 1440 | 1 to 437 | 437/437 (100 %) | 9 diff (98.0 %id) | |||
| BF371992 | prostate_tumor | .a | 1008 to 1307 | 33 to 332 | 300/332 (90 %) | 6 diff (98.2 %id) | |||
| BI260815 | cervical carcinoma cell line, cervix | .a | 1059 to 1735 | 38 to 713 | 676/713 (94 %) | 6 diff (99.2 %id) | |||
| AW364017 | colon | .a | 1060 to 1703 | 648 to 10 | 639/670 (95 %) | 0 diff (100 %id) | |||
| BQ930717 | sciatic nerve | .a | 1062 to 1800 | 1 to 746 | 746/860 (86 %) | 17 diff (98.1 %id) | |||
| AW364018 | colon | .a | 1073 to 1678 | 610 to 5 | 606/610 (99 %) | 0 diff (100 %id) | |||
| BU959068 | mixed (pool of 40 RNAs) | .a | 1088 to 1769 | 1 to 689 | 689/809 (85 %) | 19 diff (97.7 %id) | |||
| BI223371 | cervical carcinoma cell line, cervix | .a | 1119 to 1800 | 1 to 686 | 686/697 (98 %) | 11 diff (98.5 %id) | |||
| BF832747 | head_neck | .a | 1137 to 1408 | 11 to 281 | 271/290 (93 %) | 13 diff (95.6 %id) | |||
| BX505945 | .a | 1138 to 1767 | 1 to 630 | 630/630 (100 %) | 1 diff (99.9 %id) | ||||
| DA832720 | placenta | .a | 1158 to 1784 | 2 to 629 | capped | 628/634 (99 %) | 3 diff (99.6 %id) | ||
| BP206311 | coronary artery | .a | 1189 to 1750 | 1 to 562 | 562/562 (100 %) | 11 diff (98.1 %id) | |||
| CN423572 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .a | 1200 to 1888 | 11 to 699 | 689/699 (98 %) | 6 diff (99.2 %id) | |||
| CA420878 | Bone, Enchondroma cell line | .a | 1206 to 1889 | 702 to 19 | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 684/693 (98 %) | 1 diff (99.9 %id) | |
| BP294088 | Liver | .a | 1210 to 1800 | 1 to 591 | 591/592 (99 %) | 9 diff (98.5 %id) | |||
| BP294120 | Liver | .a | 1210 to 1800 | 1 to 587 | 587/587 (100 %) | 11 diff (98.2 %id) | |||
| BP356458 | mammary gland | .a | 1239 to 1818 | 1 to 582 | 582/582 (100 %) | 31 diff (94.7 %id) | |||
| BX645079 | .a | 1243 to 1889 | 1 to 649 | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 649/649 (100 %) | 5 diff (99.3 %id) | ||
| CV371130 | uterus | .a | 1257 to 1411 | 1 to 156 | 156/162 (96 %) | 14 diff (91.4 %id) | |||
| CD365961 | Alveolar Macrophage, lung | .a | 1271 to 1889 | 637 to 19 | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 619/619 (100 %) | 0 diff (100 %id) | |
| BI038297 | nervous_tumor | .a | 1313 to 1780 | 1 to 468 | 468/468 (100 %) | 0 diff (100 %id) | |||
| DB356959. matches multiple genes | whole embryo, mainly head | .a | 1317 to 1889 | 572 to 1 | also hits gene RHOJ | 572/574 (99 %) | 2 diff (99.7 %id) | ||
| BG993255 | head_neck | .a | 1329 to 1780 | 451 to 1 | 451/456 (98 %) | 4 diff (99.2 %id) | |||
| FN086356 | breast carcinoma | .a | 1354 to 1447 | 94 to 1 | Submitted on the opposite strand | 94/94 (100 %) | 2 diff (97.9 %id) | ||
| CK825254 | Pancreas, Purified pancreatic islet | .a | 1354 to 1854 | 501 to 1 | Submitted on the opposite strand | 501/501 (100 %) | 0 diff (100 %id) | ||
| DB334880 | synovial membrane tissue from rheumatioidarthritis | .a | 1808 to 2337 | 531 to 1 | 531/531 (100 %) | 2 diff (99.7 %id) | |||
| AL569342 | placenta | .a | 2331 to 3379 | 1038 to 1 | tiling clone, | 1038/1038 (100 %) | 34 diff (96.8 %id) | ||
| DB379046 | placenta | .a | 2906 to 3445 | 531 to 1 | 531/578 (91 %) | 15 diff (97.5 %id) | |||
| NM_030799.7 | .b | 1 to 3194 | 1 to 3194 | exact | RefSeq, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 3194/3194 (100 %) | 0 diff (100 %id) | |
| BP205725 | coronary artery | .b | 20 to 603 | 1 to 583 | tiling clone, | 583/583 (100 %) | 4 diff (99.4 %id) | ||
| BJ996186 | hepatoblastoma | .b | 49 to 583 | 1 to 535 | 535/535 (100 %) | 0 diff (100 %id) | |||
| BP363627 | lung | .b | 49 to 630 | 1 to 582 | 582/582 (100 %) | 8 diff (98.7 %id) | |||
| DA066986 | cerebellum | .b | 50 to 622 | 2 to 574 | capped | 573/573 (100 %) | 2 diff (99.7 %id) | ||
| BP223355 | colon mucosa | .b | 50 to 808 | 1 to 780 | 780/823 (94 %) | 31 diff (96.3 %id) | |||
| DA613235 | .b | 50 to 619 | 2 to 573 | capped | 572/572 (100 %) | 2 diff (99.7 %id) | |||
| DA831500 | placenta | .b | 50 to 723 | 2 to 675 | capped | 674/674 (100 %) | 2 diff (99.8 %id) | ||
| BG699161 | brain, hippocampus | .b | 51 to 774 | 1 to 726 | 726/729 (99 %) | 15 diff (98.0 %id) | |||
| DB056667 | testis | .b | 53 to 504 | 90 to 541 | capped | 452/540 (83 %) | 7 diff (98.8 %id) | ||
| BP222054 | .b | 54 to 635 | 1 to 582 | 582/582 (100 %) | 2 diff (99.7 %id) | ||||
| CK001228 | brain/CNS, Bulk tissue from Human Spinal cord | .b | 54 to 716 | 1 to 662 | 662/663 (99 %) | 8 diff (98.8 %id) | |||
| DA889184 | .b | 54 to 605 | 2 to 554 | capped | 553/553 (100 %) | 3 diff (99.5 %id) | |||
| BF246319 | brain, glioblastoma | .b | 55 to 596 | 1 to 544 | 546/833 (65 %) | 30 diff (96.4 %id) | |||
| BF794230 | lymph, lymphoma, cell line | .b | 55 to 802 | 7 to 758 | 752/883 (85 %) | 24 diff (97.3 %id) | |||
| DA614157 | .b | 55 to 647 | 2 to 595 | capped | 594/594 (100 %) | 1 diff (99.9 %id) | |||
| BP207798 | coronary artery | .b | 56 to 627 | 1 to 572 | 572/572 (100 %) | 1 diff (99.9 %id) | |||
| BP213214 | cerebrum | .b | 56 to 631 | 1 to 576 | 576/576 (100 %) | 3 diff (99.5 %id) | |||
| BP220587 | colon | .b | 56 to 617 | 1 to 562 | 562/562 (100 %) | 3 diff (99.5 %id) | |||
| BX421185 | B cells (Ramos cell line) | .b | 56 to 1132 | 1 to 1065 | E124X | 1065/1065 (100 %) | 19 diff (98.3 %id) | ||
| DB459395 | testis | .b | 56 to 537 | 1 to 482 | 482/482 (100 %) | 2 diff (99.6 %id) | |||
| DB469071 | hippocampus | .b | 56 to 491 | 1 to 435 | 435/435 (100 %) | 2 diff (99.6 %id) | |||
| BP360033 | thalamus | .b | 56 to 620 | 1 to 566 | 566/581 (97 %) | 4 diff (99.4 %id) | |||
| BP374720 | umbilical cord | .b | 56 to 636 | 1 to 581 | 581/581 (100 %) | 4 diff (99.4 %id) | |||
| DA362572 | subthalamic nucleus | .b | 57 to 619 | 2 to 565 | capped | 564/564 (100 %) | 2 diff (99.7 %id) | ||
| DA611785 | .b | 57 to 634 | 2 to 579 | capped | 578/578 (100 %) | 0 diff (100 %id) | |||
| DA890121 | rectum | .b | 57 to 445 | 2 to 390 | capped | 389/389 (100 %) | 0 diff (100 %id) | ||
| DA594378 | lung | .b | 58 to 618 | 2 to 563 | capped | 562/562 (100 %) | 1 diff (99.9 %id) | ||
| DA268308 | caudate nucleus | .b | 59 to 624 | 2 to 568 | capped | 567/567 (100 %) | 2 diff (99.7 %id) | ||
| DB267588 | uterus | .b | 59 to 644 | 2 to 587 | capped | 586/586 (100 %) | 0 diff (100 %id) | ||
| BP211270 | cerebellum | .b | 60 to 655 | 1 to 594 | 594/594 (100 %) | 4 diff (99.4 %id) | |||
| BP229338 | brain | .b | 60 to 641 | 1 to 582 | 582/582 (100 %) | 8 diff (98.7 %id) | |||
| DA886642 | .b | 60 to 609 | 2 to 553 | capped | 552/552 (100 %) | 3 diff (99.5 %id) | |||
| BP277931 | .b | 61 to 647 | 1 to 588 | 588/588 (100 %) | 3 diff (99.5 %id) | ||||
| BP195061 | brain | .b | 62 to 643 | 1 to 582 | 582/582 (100 %) | 1 diff (99.9 %id) | |||
| BP195582 | brain | .b | 62 to 643 | 1 to 582 | 582/582 (100 %) | 5 diff (99.2 %id) | |||
| BX647859 | human adipose | .b | 62 to 2086 | 1 to 2025 | P52L P53S D54R M55H M56D ... | available from DKFZ, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 2025/2025 (100 %) | 4 diff (99.9 %id) |
| BP204749 | coronary artery | .b | 62 to 643 | 1 to 582 | 582/582 (100 %) | 3 diff (99.5 %id) | |||
| CR749463 | adipose | .b | 62 to 2086 | 1 to 2024 | exact | available from DKFZ, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 2024/2024 (100 %) | 3 diff (99.9 %id) |
| BG472579 | eye, retinoblastoma | .b | 62 to 512 | 1 to 461 | 461/482 (95 %) | 15 diff (96.9 %id) | |||
| BM050421 | eye, normal pigmented retinal epithelium | .b | 62 to 709 | 1 to 648 | 648/648 (100 %) | 7 diff (99.0 %id) | |||
| CB140497 | Liver | .b | 62 to 493 | 1 to 432 | 432/432 (100 %) | 1 diff (99.8 %id) | |||
| DA005232 | .b | 63 to 626 | 2 to 566 | capped | 565/565 (100 %) | 1 diff (99.9 %id) | |||
| BC014253 | Eye, retinoblastoma | .b | 63 to 1638 | 1 to 1577 | exact | available from MGC, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 1577/1577 (100 %) | 2 diff (99.9 %id) |
| DA405618 | thalamus | .b | 63 to 630 | 2 to 570 | capped | 569/569 (100 %) | 1 diff (99.9 %id) | ||
| BP203786 | coronary artery | .b | 63 to 619 | 1 to 557 | 557/574 (97 %) | 17 diff (97.1 %id) | |||
| BP204240 | coronary artery | .b | 63 to 645 | 1 to 583 | 583/583 (100 %) | 0 diff (100 %id) | |||
| DW408530 | Liver | .b | 63 to 385 | 19 to 343 | 325/343 (94 %) | 11 diff (96.8 %id) | |||
| DW408531 | Liver | .b | 63 to 387 | 19 to 343 | 325/343 (94 %) | 8 diff (97.7 %id) | |||
| ES310694 | scalp interfollicular dermis, skin | .b | 63 to 486 | 1 to 424 | 424/424 (100 %) | 0 diff (100 %id) | |||
| BP259571 | heart | .b | 63 to 631 | 1 to 569 | 569/569 (100 %) | 0 diff (100 %id) | |||
| BM911300 | astrocytoma grade IV, cell line, brain | .b | 63 to 802 | 18 to 760 | 743/1091 (68 %) | 24 diff (97.9 %id) | |||
| CB124930 | Liver | .b | 63 to 649 | 1 to 587 | 587/587 (100 %) | 2 diff (99.7 %id) | |||
| DA819931 | .b | 63 to 624 | 2 to 564 | capped | 563/563 (100 %) | 1 diff (99.9 %id) | |||
| DA829535 | placenta | .b | 63 to 801 | 2 to 743 | capped | 742/800 (92 %) | 10 diff (98.8 %id) | ||
| DA831342 | placenta | .b | 63 to 664 | 2 to 603 | capped | 602/614 (98 %) | 7 diff (98.9 %id) | ||
| DA832083 | placenta | .b | 63 to 776 | 2 to 720 | capped | 719/719 (100 %) | 16 diff (97.8 %id) | ||
| DA873567 | Prostate | .b | 63 to 618 | 2 to 558 | capped | 557/557 (100 %) | 2 diff (99.7 %id) | ||
| BM788707 | stomach | .b | 63 to 672 | 1 to 610 | 610/610 (100 %) | 1 diff (99.9 %id) | |||
| DN995852 | breast cancer, Mammary gland (cancer tissue) | .b | 63 to 297 | 9 to 243 | 235/243 (96 %) | 6 diff (97.6 %id) | |||
| DB114702 | thymus | .b | 63 to 618 | 2 to 557 | capped | 556/556 (100 %) | 1 diff (99.9 %id) | ||
| DB129360 | thymus | .b | 63 to 615 | 2 to 554 | capped | 553/553 (100 %) | 1 diff (99.9 %id) | ||
| BP363479 | lung | .b | 63 to 646 | 1 to 582 | 582/582 (100 %) | 3 diff (99.5 %id) | |||
| BP365357 | lung | .b | 63 to 653 | 1 to 592 | 592/592 (100 %) | 1 diff (99.9 %id) | |||
| DA018503 | .b | 64 to 624 | 2 to 563 | capped | 562/562 (100 %) | 2 diff (99.7 %id) | |||
| AK054576 | .b | 64 to 1638 | 1 to 1575 | exact | available from FLJ, | 1575/1575 (100 %) | 3 diff (99.9 %id) | ||
| DA341434 | substantia nigra | .b | 64 to 650 | 2 to 588 | capped | 587/587 (100 %) | 2 diff (99.7 %id) | ||
| DA475993 | .b | 64 to 639 | 2 to 578 | capped | 577/577 (100 %) | 2 diff (99.7 %id) | |||
| DA520967 | brain | .b | 64 to 618 | 2 to 556 | capped | 555/555 (100 %) | 1 diff (99.9 %id) | ||
| DA530133 | brain | .b | 64 to 668 | 2 to 606 | capped | 605/605 (100 %) | 0 diff (100 %id) | ||
| CX753814 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .b | 64 to 760 | 1 to 691 | Submitted on the opposite strand | 691/834 (82 %) | 11 diff (98.7 %id) | ||
| DR155561 | human embryonic stem cells differentiated toan early endodermal cell type | .b | 64 to 847 | 1 to 784 | 784/784 (100 %) | 0 diff (100 %id) | |||
| DA631394 | Kidney | .b | 64 to 640 | 2 to 579 | capped | 578/578 (100 %) | 2 diff (99.7 %id) | ||
| DA948615 | Spleen | .b | 64 to 623 | 2 to 562 | capped | 561/561 (100 %) | 1 diff (99.9 %id) | ||
| DB034391 | testis | .b | 64 to 639 | 2 to 577 | capped | 576/576 (100 %) | 1 diff (99.9 %id) | ||
| DB183366 | liver, tumor tissue | .b | 64 to 638 | 2 to 581 | capped | 580/580 (100 %) | 5 diff (99.2 %id) | ||
| DB205242 | trachea | .b | 64 to 541 | 2 to 479 | capped | 478/478 (100 %) | 1 diff (99.8 %id) | ||
| DA000420 | .b | 65 to 595 | 2 to 533 | capped | 532/532 (100 %) | 3 diff (99.5 %id) | |||
| BP206301 | coronary artery | .b | 65 to 636 | 1 to 573 | 573/573 (100 %) | 3 diff (99.5 %id) | |||
| CD693075 | normal nasopharynx | .b | 65 to 650 | 1 to 587 | 587/587 (100 %) | 6 diff (99.0 %id) | |||
| DA615002 | .b | 65 to 634 | 2 to 571 | capped | 570/570 (100 %) | 1 diff (99.9 %id) | |||
| CB136518 | Liver | .b | 65 to 551 | 1 to 487 | 487/487 (100 %) | 0 diff (100 %id) | |||
| CB149513 | Liver | .b | 65 to 573 | 1 to 509 | 509/509 (100 %) | 1 diff (99.9 %id) | |||
| BP352184 | .b | 65 to 639 | 1 to 576 | 576/576 (100 %) | 8 diff (98.7 %id) | ||||
| BP370804 | testis | .b | 65 to 624 | 1 to 560 | 560/560 (100 %) | 0 diff (100 %id) | |||
| BC024737 | Cervix, carcinoma | .b | 66 to 1638 | 1 to 1574 | exact | available from MGC, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 1574/1574 (100 %) | 2 diff (99.9 %id) |
| DA060286 | cerebellum | .b | 66 to 619 | 2 to 556 | capped | 555/555 (100 %) | 1 diff (99.9 %id) | ||
| BP204659 | coronary artery | .b | 66 to 649 | 1 to 584 | 584/584 (100 %) | 1 diff (99.9 %id) | |||
| BP236818 | coronary artery | .b | 66 to 646 | 1 to 582 | 582/582 (100 %) | 2 diff (99.7 %id) | |||
| BP254249 | Kidney | .b | 66 to 648 | 1 to 583 | 583/583 (100 %) | 1 diff (99.9 %id) | |||
| DA618193 | .b | 66 to 663 | 2 to 601 | capped | 600/600 (100 %) | 2 diff (99.7 %id) | |||
| BP277102 | Kidney | .b | 66 to 647 | 1 to 582 | 582/582 (100 %) | 1 diff (99.9 %id) | |||
| CB106391 | Liver | .b | 66 to 462 | 1 to 398 | 398/398 (100 %) | 2 diff (99.5 %id) | |||
| CB131246 | Liver | .b | 66 to 671 | 1 to 606 | 606/606 (100 %) | 0 diff (100 %id) | |||
| BP289659 | lung | .b | 66 to 621 | 1 to 557 | 557/586 (95 %) | 15 diff (97.5 %id) | |||
| DB057964 | testis | .b | 66 to 613 | 2 to 550 | capped | 549/549 (100 %) | 1 diff (99.9 %id) | ||
| DA063999 | cerebellum | .b | 67 to 620 | 2 to 555 | capped | 554/562 (98 %) | 1 diff (99.9 %id) | ||
| DA385189 | thalamus | .b | 67 to 584 | 2 to 520 | capped | 519/519 (100 %) | 1 diff (99.9 %id) | ||
| DA625024 | Kidney | .b | 67 to 613 | 2 to 548 | capped | 547/547 (100 %) | 0 diff (100 %id) | ||
| DA655299 | .b | 67 to 650 | 2 to 586 | capped | 585/585 (100 %) | 1 diff (99.9 %id) | |||
| DA783743 | brain | .b | 67 to 639 | 2 to 575 | capped | 574/574 (100 %) | 2 diff (99.7 %id) | ||
| DA902136 | .b | 67 to 649 | 2 to 585 | capped | 584/584 (100 %) | 1 diff (99.9 %id) | |||
| DA980009 | synovial membrane tissue from rheumatioidarthritis | .b | 67 to 619 | 2 to 556 | capped | 555/555 (100 %) | 1 diff (99.9 %id) | ||
| DB046739 | testis | .b | 67 to 622 | 2 to 558 | capped | 557/557 (100 %) | 2 diff (99.7 %id) | ||
| DB090374 | testis | .b | 67 to 638 | 2 to 574 | capped | 573/573 (100 %) | 1 diff (99.9 %id) | ||
| DB208654 | trachea | .b | 67 to 519 | 2 to 457 | capped | 456/456 (100 %) | 3 diff (99.4 %id) | ||
| DB243694 | stomach, tumor tissue | .b | 67 to 619 | 2 to 556 | capped | 555/555 (100 %) | 2 diff (99.7 %id) | ||
| CN423570 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .b | 68 to 707 | 1 to 639 | 639/639 (100 %) | 6 diff (99.1 %id) | |||
| BX458543 | placenta | .b | 72 to 1126 | 1 to 1041 | exact | 1041/1041 (100 %) | 19 diff (98.2 %id) | ||
| AY037152 | .b | 73 to 1270 | 5 to 1202 | C187W | AAA | 1198/1644 (72 %) | 8 diff (99.6 %id) | ||
| BU950527 | Pancreas, Purified pancreatic islet | .b | 73 to 739 | 8 to 674 | 667/674 (98 %) | 6 diff (99.2 %id) | |||
| CB955658 | Pooled-Glandular | .b | 73 to 588 | 1 to 512 | 512/577 (88 %) | 8 diff (98.7 %id) | |||
| BP278885 | .b | 73 to 620 | 1 to 547 | 547/577 (94 %) | 14 diff (97.6 %id) | ||||
| BG682599 | skin, squamous cell carcinoma | .b | 74 to 920 | 1 to 861 | 782/941 (83 %) | 23 diff (97.6 %id) | |||
| DA070908 | cerebellum | .b | 75 to 647 | 2 to 574 | capped | 573/573 (100 %) | 0 diff (100 %id) | ||
| BX428063 | fetal liver, Liver | .b | 75 to 913 | 1 to 838 | 838/838 (100 %) | 2 diff (99.8 %id) | |||
| BF675022 | Prostate | .b | 75 to 619 | 1 to 544 | 546/870 (62 %) | 18 diff (98.0 %id) | |||
| BG424866 | Kidney, renal cell adenocarcinoma | .b | 75 to 805 | 1 to 723 | 725/844 (85 %) | 36 diff (95.8 %id) | |||
| CD632797 | .b | 76 to 615 | 543 to 5 | 539/550 (98 %) | 2 diff (99.7 %id) | ||||
| CD632798 | .b | 76 to 619 | 8 to 552 | 545/554 (98 %) | 13 diff (97.7 %id) | ||||
| CD632799 | .b | 76 to 615 | 545 to 5 | 541/552 (98 %) | 0 diff (100 %id) | ||||
| CD632800 | .b | 76 to 619 | 8 to 553 | 546/555 (98 %) | 13 diff (97.7 %id) | ||||
| CD632801 | .b | 76 to 615 | 545 to 5 | 541/552 (98 %) | 0 diff (100 %id) | ||||
| CD632802 | .b | 76 to 619 | 8 to 553 | 546/555 (98 %) | 13 diff (97.7 %id) | ||||
| CD632803 | .b | 76 to 615 | 545 to 6 | 540/552 (97 %) | 0 diff (100 %id) | ||||
| CD632804 | .b | 76 to 619 | 8 to 552 | 545/554 (98 %) | 12 diff (97.9 %id) | ||||
| BP222609 | .b | 76 to 650 | 1 to 575 | 575/582 (98 %) | 1 diff (99.9 %id) | ||||
| BP281362 | bone marrow | .b | 76 to 646 | 1 to 575 | 575/575 (100 %) | 18 diff (96.9 %id) | |||
| BP281864 | bone marrow | .b | 76 to 652 | 1 to 578 | 578/583 (99 %) | 4 diff (99.4 %id) | |||
| DR422888 | eye, Pterygium | .b | 76 to 797 | 1 to 722 | 722/722 (100 %) | 2 diff (99.8 %id) | |||
| BP307952 | brain | .b | 76 to 652 | 1 to 578 | 578/581 (99 %) | 3 diff (99.5 %id) | |||
| AA305800 | colon | .b | 77 to 416 | 1 to 339 | 339/339 (100 %) | 5 diff (98.6 %id) | |||
| DA115508 | cerebellum | .b | 77 to 586 | 2 to 513 | capped | 512/512 (100 %) | 2 diff (99.7 %id) | ||
| BX418371 | brain, fetal brain | .b | 77 to 964 | 1 to 887 | S2X F4X F11X Y12D Y16X ... | 887/887 (100 %) | 13 diff (98.6 %id) | ||
| BX423242 | brain, fetal brain | .b | 77 to 1050 | 1 to 965 | K115X | 965/1021 (94 %) | 11 diff (99.0 %id) | ||
| DA604048 | .b | 77 to 584 | 2 to 509 | capped | 508/508 (100 %) | 1 diff (99.9 %id) | |||
| DA906311 | .b | 77 to 650 | 2 to 575 | capped | 574/574 (100 %) | 0 diff (100 %id) | |||
| DB043055 | testis | .b | 77 to 635 | 2 to 561 | capped | 560/560 (100 %) | 1 diff (99.9 %id) | ||
| DB091592 | testis | .b | 77 to 636 | 2 to 562 | capped | 561/561 (100 %) | 1 diff (99.9 %id) | ||
| BP202518 | amygdala | .b | 78 to 658 | 1 to 582 | 582/582 (100 %) | 2 diff (99.7 %id) | |||
| BP204721 | coronary artery | .b | 78 to 545 | 1 to 467 | 467/550 (84 %) | 23 diff (95.9 %id) | |||
| R57135 | .b | 78 to 222 | 1 to 148 | 148/151 (98 %) | 7 diff (95.4 %id) | ||||
| DB483816 | hippocampus | .b | 78 to 534 | 1 to 457 | 457/457 (100 %) | 1 diff (99.8 %id) | |||
| BP235233 | coronary artery | .b | 78 to 659 | 1 to 582 | 582/582 (100 %) | 5 diff (99.2 %id) | |||
| BP236790 | coronary artery | .b | 78 to 651 | 1 to 575 | 575/582 (98 %) | 3 diff (99.5 %id) | |||
| BP252674 | Kidney | .b | 78 to 625 | 1 to 549 | 549/581 (94 %) | 16 diff (97.3 %id) | |||
| BP278733 | .b | 78 to 665 | 1 to 589 | 589/589 (100 %) | 8 diff (98.7 %id) | ||||
| BP278780 | .b | 78 to 659 | 1 to 582 | 582/582 (100 %) | 3 diff (99.5 %id) | ||||
| BP297791 | .b | 78 to 660 | 1 to 583 | 583/583 (100 %) | 0 diff (100 %id) | ||||
| BP323274 | Pancreas | .b | 78 to 659 | 1 to 582 | 582/583 (99 %) | 10 diff (98.3 %id) | |||
| DA020233 | .b | 79 to 637 | 2 to 561 | capped | 560/560 (100 %) | 2 diff (99.7 %id) | |||
| DA030514 | .b | 79 to 635 | 2 to 558 | capped | 557/557 (100 %) | 0 diff (100 %id) | |||
| DA123653 | cerebellum | .b | 79 to 624 | 2 to 548 | capped | 547/547 (100 %) | 3 diff (99.5 %id) | ||
| DA570979 | whole embryo, mainly head | .b | 79 to 928 | 2 to 851 | capped | 850/850 (100 %) | 1 diff (99.9 %id) | ||
| DA603552 | .b | 79 to 871 | 2 to 796 | capped | 795/795 (100 %) | 4 diff (99.5 %id) | |||
| DA919122 | small intestine | .b | 79 to 641 | 2 to 565 | capped | 564/564 (100 %) | 2 diff (99.7 %id) | ||
| DB135064 | thymus | .b | 79 to 624 | 2 to 547 | capped | 546/546 (100 %) | 0 diff (100 %id) | ||
| DB188471 | liver, tumor tissue | .b | 79 to 649 | 2 to 572 | capped | 571/571 (100 %) | 0 diff (100 %id) | ||
| BG249406 | hypernephroma, cell line, Kidney | .b | 80 to 787 | 1 to 713 | 713/776 (91 %) | 24 diff (97.0 %id) | |||
| BG742644 | skin | .b | 80 to 935 | 1 to 858 | 858/858 (100 %) | 18 diff (98.0 %id) | |||
| BG717275 | testis | .b | 80 to 543 | 1 to 462 | 462/464 (99 %) | 6 diff (98.8 %id) | |||
| DB086211 | testis | .b | 80 to 639 | 2 to 562 | capped | 561/561 (100 %) | 1 diff (99.9 %id) | ||
| BI091083 | cervix | .b | 81 to 677 | 1 to 606 | 604/820 (73 %) | 29 diff (96.5 %id) | |||
| BQ716925 | sympathetic trunk | .b | 81 to 971 | 1 to 894 | W218M C219V S220* | 894/895 (99 %) | 4 diff (99.6 %id) | ||
| CV808905 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .b | 81 to 823 | 1 to 743 | 743/743 (100 %) | 3 diff (99.6 %id) | |||
| CX754838 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .b | 81 to 799 | 1 to 719 | Submitted on the opposite strand | 719/719 (100 %) | 0 diff (100 %id) | ||
| BP269722 | thyroid | .b | 81 to 659 | 1 to 580 | 580/580 (100 %) | 3 diff (99.5 %id) | |||
| DA346064 | substantia nigra | .b | 82 to 667 | 2 to 587 | capped | 586/586 (100 %) | 0 diff (100 %id) | ||
| DA424048 | .b | 82 to 627 | 2 to 548 | capped | 547/547 (100 %) | 1 diff (99.9 %id) | |||
| BP200051 | amygdala | .b | 83 to 666 | 1 to 583 | 583/583 (100 %) | 1 diff (99.9 %id) | |||
| BC007829 | Uterus, endometrium adenocarcinoma | .b | 83 to 1638 | 1 to 1558 | exact | available from MGC, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 1558/1558 (100 %) | 3 diff (99.9 %id) |
| BG699067 | brain, hippocampus | .b | 83 to 801 | 1 to 718 | 718/732 (98 %) | 15 diff (98.0 %id) | |||
| BG699678 | brain, hippocampus | .b | 83 to 767 | 1 to 685 | 685/814 (84 %) | 22 diff (97.3 %id) | |||
| BQ710963 | Spleen | .b | 84 to 936 | 1 to 867 | 867/964 (89 %) | 30 diff (96.9 %id) | |||
| BP192995 | brain | .b | 85 to 666 | 1 to 582 | 582/582 (100 %) | 7 diff (98.8 %id) | |||
| AY640925 | .b | 85 to 2086 | 1 to 2002 | exact | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 2002/2002 (100 %) | 1 diff (100.0 %id) | |
| AY640926 | .b | 85 to 3194 | 1 to 3110 | exact | tiling clone, AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 3110/3110 (100 %) | 0 diff (100 %id) | |
| AY640927 | .b | 85 to 1638 | 1 to 1554 | exact | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 1554/1554 (100 %) | 0 diff (100 %id) | |
| BP206129 | coronary artery | .b | 85 to 665 | 1 to 581 | 581/581 (100 %) | 2 diff (99.7 %id) | |||
| AU279904 | .b | 85 to 658 | 1 to 574 | 574/574 (100 %) | 0 diff (100 %id) | ||||
| BQ949791 | large cell carcinoma, lung | .b | 85 to 926 | 1 to 844 | 844/847 (99 %) | 8 diff (99.1 %id) | |||
| BP377342 | uterus | .b | 85 to 660 | 1 to 577 | 577/584 (98 %) | 6 diff (99.0 %id) | |||
| BP194744 | brain | .b | 86 to 669 | 1 to 582 | 582/582 (100 %) | 4 diff (99.4 %id) | |||
| DA029195 | .b | 86 to 649 | 2 to 565 | capped | 564/564 (100 %) | 0 diff (100 %id) | |||
| DA031159 | .b | 86 to 638 | 2 to 554 | capped | 553/553 (100 %) | 1 diff (99.9 %id) | |||
| DA125668 | cerebellum | .b | 86 to 649 | 2 to 565 | capped | 564/564 (100 %) | 0 diff (100 %id) | ||
| DA163343 | amygdala | .b | 86 to 649 | 2 to 565 | capped | 564/564 (100 %) | 0 diff (100 %id) | ||
| BP208016 | cerebellum | .b | 86 to 665 | 1 to 580 | 580/580 (100 %) | 2 diff (99.7 %id) | |||
| BP211193 | cerebellum | .b | 86 to 674 | 1 to 588 | 588/588 (100 %) | 5 diff (99.2 %id) | |||
| DA519824 | brain | .b | 86 to 645 | 2 to 562 | capped | 561/561 (100 %) | 1 diff (99.9 %id) | ||
| DA553036 | .b | 86 to 641 | 2 to 557 | capped | 556/556 (100 %) | 0 diff (100 %id) | |||
| DA571458 | whole embryo, mainly head | .b | 86 to 906 | 2 to 824 | capped | 823/825 (99 %) | 9 diff (99.0 %id) | ||
| BP264110 | small intestine | .b | 86 to 556 | 1 to 472 | 472/580 (81 %) | 25 diff (95.7 %id) | |||
| BF793125 | adrenal cortex carcinoma, cell line, adrenal gland | .b | 86 to 800 | 1 to 721 | 721/918 (78 %) | 8 diff (99.2 %id) | |||
| BI770458 | pooled lung and spleen | .b | 86 to 844 | 1 to 749 | 749/750 (99 %) | 12 diff (98.4 %id) | |||
| DA614291 | .b | 86 to 653 | 2 to 569 | capped | 568/568 (100 %) | 1 diff (99.9 %id) | |||
| DA651263 | .b | 86 to 629 | 2 to 545 | capped | 544/544 (100 %) | 0 diff (100 %id) | |||
| DA818563 | .b | 86 to 652 | 2 to 568 | capped | 567/567 (100 %) | 0 diff (100 %id) | |||
| BP320229 | placenta | .b | 86 to 693 | 1 to 609 | 609/609 (100 %) | 5 diff (99.2 %id) | |||
| DB043525 | testis | .b | 86 to 651 | 2 to 567 | capped | 566/566 (100 %) | 0 diff (100 %id) | ||
| DB082973 | testis | .b | 86 to 638 | 2 to 554 | capped | 553/553 (100 %) | 0 diff (100 %id) | ||
| BP362156 | thalamus | .b | 86 to 665 | 1 to 582 | 582/582 (100 %) | 4 diff (99.4 %id) | |||
| BP366071 | lung | .b | 86 to 667 | 1 to 582 | 582/582 (100 %) | 4 diff (99.4 %id) | |||
| DB199394 | trachea | .b | 86 to 661 | 2 to 577 | capped | 576/576 (100 %) | 1 diff (99.9 %id) | ||
| DA412846 | thalamus | .b | 87 to 623 | 2 to 538 | capped | 537/537 (100 %) | 0 diff (100 %id) | ||
| BU150881 | dorsal root ganglia | .b | 87 to 980 | 1 to 898 | K146R F227L I228F S229L A230H ... | 898/908 (98 %) | 13 diff (98.6 %id) | ||
| TI_57179728 | .b | 87 to 844 | 58 to 805 | 748/806 (92 %) | 14 diff (98.3 %id) | ||||
| BF967229 | brain, hypothalamus | .b | 88 to 769 | 10 to 678 | 671/800 (83 %) | 24 diff (97.0 %id) | |||
| CD705453 | normal nasopharynx | .b | 91 to 383 | 18 to 310 | 293/310 (94 %) | 9 diff (97.1 %id) | |||
| CD705635 | normal nasopharynx | .b | 91 to 442 | 21 to 371 | 353/371 (95 %) | 9 diff (97.6 %id) | |||
| AL599810 | .b | 91 to 711 | 20 to 642 | 623/642 (97 %) | 6 diff (99.1 %id) | ||||
| BF245290 | brain, glioblastoma | .b | 93 to 651 | 1 to 556 | 556/556 (100 %) | 11 diff (98.1 %id) | |||
| BQ650570 | hepatocellular carcinoma, cell line, Liver | .b | 95 to 798 | 1 to 705 | 705/888 (79 %) | 8 diff (99.1 %id) | |||
| BQ645505 | hepatocellular carcinoma, cell line, Liver | .b | 95 to 886 | 1 to 800 | 800/947 (84 %) | 23 diff (97.6 %id) | |||
| BQ646289 | hepatocellular carcinoma, cell line, Liver | .b | 95 to 933 | 1 to 849 | 849/916 (92 %) | 18 diff (98.1 %id) | |||
| BQ652735 | hepatocellular carcinoma, cell line, Liver | .b | 95 to 994 | 1 to 904 | Q204P G208X C219G I226Y F227L ... | 904/947 (95 %) | 23 diff (97.6 %id) | ||
| CB131276 | Liver | .b | 95 to 700 | 1 to 607 | 607/607 (100 %) | 3 diff (99.6 %id) | |||
| EL948672 | eyeball | .b | 98 to 473 | 1 to 378 | 378/380 (99 %) | 12 diff (96.9 %id) | |||
| BE896822 | melanotic melanoma, skin | .b | 98 to 773 | 1 to 690 | 690/794 (86 %) | 17 diff (97.9 %id) | |||
| CN423569 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .b | 100 to 832 | 9 to 741 | 733/745 (98 %) | 10 diff (98.7 %id) | |||
| AW401534 | lymph | .b | 101 to 268 | 8 to 175 | 168/175 (96 %) | 6 diff (96.6 %id) | |||
| AA375715 | lung | .b | 102 to 388 | 1 to 287 | 287/287 (100 %) | 2 diff (99.4 %id) | |||
| BP204531 | coronary artery | .b | 102 to 686 | 1 to 585 | 585/585 (100 %) | 4 diff (99.4 %id) | |||
| CN423564 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .b | 102 to 782 | 1 to 682 | 682/682 (100 %) | 6 diff (99.2 %id) | |||
| BE395704 | endometrium, adenocarcinoma cell line, uterus | .b | 102 to 730 | 1 to 624 | 624/624 (100 %) | 7 diff (98.9 %id) | |||
| DA678787 | .b | 103 to 389 | 2 to 288 | capped | 287/320 (89 %) | 1 diff (99.7 %id) | |||
| BF382749 | brain, primitive neuroectoderm | .b | 104 to 806 | 1 to 697 | 699/874 (79 %) | 39 diff (95.6 %id) | |||
| EC551516 | Prostate | .b | 106 to 212 | 1 to 101 | 101/102 (99 %) | 8 diff (92.2 %id) | |||
| AA356684 | .b | 107 to 420 | 1 to 313 | 313/313 (100 %) | 1 diff (99.7 %id) | ||||
| EC498053 | Prostate | .b | 107 to 212 | 1 to 105 | 105/105 (100 %) | 1 diff (99.1 %id) | |||
| CD657305 | Embryonic Stem cells | .b | 107 to 893 | 12 to 791 | 780/807 (96 %) | 18 diff (97.8 %id) | |||
| AW964084 | .b | 108 to 708 | 1 to 599 | 599/599 (100 %) | 5 diff (99.2 %id) | ||||
| BP205523 | coronary artery | .b | 109 to 691 | 1 to 584 | 584/584 (100 %) | 15 diff (97.5 %id) | |||
| CD519297 | White Matter | .b | 109 to 977 | 1 to 875 | I226Y F227L I228F S229L A230H ... | 875/875 (100 %) | 10 diff (98.9 %id) | ||
| DA141658 | alzheimer cortex | .b | 110 to 651 | 2 to 543 | capped | 542/542 (100 %) | 0 diff (100 %id) | ||
| BP205342 | coronary artery | .b | 110 to 692 | 1 to 582 | 582/582 (100 %) | 2 diff (99.7 %id) | |||
| DA544480 | .b | 111 to 649 | 2 to 540 | capped | 539/539 (100 %) | 1 diff (99.9 %id) | |||
| AF318329 | .b | 112 to 1638 | 1 to 1530 | exact | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 1530/1530 (100 %) | 7 diff (99.6 %id) | |
| DA578556 | .b | 112 to 678 | 2 to 568 | capped | 567/567 (100 %) | 0 diff (100 %id) | |||
| BM310949 | Pancreas, Purified pancreatic islet | .b | 113 to 742 | 1 to 630 | 630/630 (100 %) | 0 diff (100 %id) | |||
| BG505011 | embryonal carcinoma, testis | .b | 113 to 799 | 1 to 687 | 687/805 (85 %) | 12 diff (98.6 %id) | |||
| DA603082 | .b | 115 to 679 | 2 to 566 | capped | 565/565 (100 %) | 0 diff (100 %id) | |||
| AA171435 | .b | 115 to 543 | 1 to 429 | 429/430 (99 %) | 2 diff (99.6 %id) | ||||
| BF668388 | brain, primitive neuroectoderm | .b | 115 to 696 | 1 to 569 | 574/824 (69 %) | 28 diff (96.7 %id) | |||
| DA548366 | .b | 116 to 672 | 2 to 558 | capped | 557/557 (100 %) | 1 diff (99.9 %id) | |||
| AY358863 | .b | 117 to 2092 | 1 to 1976 | exact | 1976/1976 (100 %) | 1 diff (100.0 %id) | |||
| CD632806 | .b | 117 to 805 | 1 to 681 | 683/686 (99 %) | 18 diff (97.4 %id) | ||||
| BG745237 | Spleen | .b | 124 to 761 | 1 to 641 | 641/1012 (63 %) | 19 diff (98.2 %id) | |||
| BP204546 | coronary artery | .b | 125 to 708 | 1 to 586 | 586/588 (99 %) | 4 diff (99.4 %id) | |||
| BU949478 | Pancreas, Purified pancreatic islet | .b | 125 to 758 | 1 to 633 | 633/633 (100 %) | 9 diff (98.6 %id) | |||
| DA363040 | subthalamic nucleus | .b | 126 to 677 | 2 to 553 | capped | 552/552 (100 %) | 0 diff (100 %id) | ||
| BQ710172 | Spleen | .b | 126 to 1009 | 1 to 890 | G208X S255F V256R F257L | 890/900 (98 %) | 11 diff (98.8 %id) | ||
| CV803260 | Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass | .b | 126 to 802 | 1 to 675 | 675/859 (78 %) | 3 diff (99.7 %id) | |||
| CN423568 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .b | 128 to 769 | 1 to 643 | 643/643 (100 %) | 2 diff (99.7 %id) | |||
| CN423573 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .b | 132 to 782 | 1 to 652 | 652/652 (100 %) | 2 diff (99.7 %id) | |||
| CN423566 | embryonic stem cells, DMSO-treated H9 cellline | .b | 134 to 723 | 1 to 590 | 590/590 (100 %) | 0 diff (100 %id) | |||
| BU941511 | mixed (pool of 40 RNAs) | .b | 135 to 620 | 1 to 495 | 495/771 (64 %) | 17 diff (97.8 %id) | |||
| CB120933 | Liver | .b | 135 to 273 | 1 to 139 | 139/139 (100 %) | 0 diff (100 %id) | |||
| DA690872 | .b | 136 to 708 | 2 to 574 | capped | 573/573 (100 %) | 1 diff (99.9 %id) | |||
| DA708805 | .b | 136 to 739 | 2 to 605 | capped | 604/604 (100 %) | 3 diff (99.6 %id) | |||
| BP253743 | Kidney | .b | 137 to 719 | 1 to 583 | 583/583 (100 %) | 1 diff (99.9 %id) | |||
| BP194094 | brain | .b | 138 to 718 | 1 to 581 | 581/581 (100 %) | 0 diff (100 %id) | |||
| AK223515 | .b | 138 to 1656 | 1 to 1520 | C244R | 1520/1525 (99 %) | 7 diff (99.6 %id) | |||
| BP204401 | coronary artery | .b | 138 to 717 | 1 to 582 | 582/582 (100 %) | 9 diff (98.5 %id) | |||
| BP204562 | coronary artery | .b | 138 to 720 | 1 to 583 | 583/583 (100 %) | 2 diff (99.7 %id) | |||
| BP204837 | coronary artery | .b | 138 to 769 | 1 to 632 | 632/632 (100 %) | 20 diff (96.9 %id) | |||
| BP205134 | coronary artery | .b | 138 to 720 | 1 to 582 | 582/582 (100 %) | 7 diff (98.8 %id) | |||
| BP205418 | coronary artery | .b | 138 to 717 | 1 to 580 | 580/580 (100 %) | 1 diff (99.9 %id) | |||
| BP205679 | coronary artery | .b | 138 to 719 | 1 to 582 | 582/582 (100 %) | 0 diff (100 %id) | |||
| BP206020 | coronary artery | .b | 138 to 717 | 1 to 580 | 580/580 (100 %) | 0 diff (100 %id) | |||
| BP207468 | coronary artery | .b | 138 to 718 | 1 to 581 | 581/582 (99 %) | 1 diff (99.9 %id) | |||
| BP207741 | coronary artery | .b | 138 to 720 | 1 to 582 | 582/582 (100 %) | 6 diff (99.0 %id) | |||
| BP207960 | coronary artery | .b | 138 to 716 | 1 to 579 | 579/581 (99 %) | 4 diff (99.4 %id) | |||
| BP208304 | cerebellum | .b | 138 to 720 | 1 to 583 | 583/583 (100 %) | 0 diff (100 %id) | |||
| CB106516 | Liver | .b | 138 to 651 | 1 to 514 | 514/514 (100 %) | 0 diff (100 %id) | |||
| DB169221 | kidney, tumor tissue | .b | 138 to 719 | 2 to 583 | capped | 582/582 (100 %) | 0 diff (100 %id) | ||
| DA543883 | .b | 139 to 695 | 2 to 558 | capped | 557/557 (100 %) | 2 diff (99.7 %id) | |||
| DA568808 | whole embryo, mainly head | .b | 139 to 994 | 2 to 852 | C187X C219W S220K S222F A223C ... | capped | 851/853 (99 %) | 14 diff (98.4 %id) | |
| DA601872 | .b | 139 to 647 | 2 to 511 | capped | 510/510 (100 %) | 1 diff (99.9 %id) | |||
| DA885699 | .b | 139 to 704 | 2 to 567 | capped | 566/566 (100 %) | 1 diff (99.9 %id) | |||
| BP336090 | coronary artery | .b | 139 to 739 | 1 to 601 | 601/601 (100 %) | 0 diff (100 %id) | |||
| BP336354 | coronary artery | .b | 139 to 722 | 1 to 582 | 582/582 (100 %) | 2 diff (99.7 %id) | |||
| BQ694872 | adipose | .b | 140 to 750 | 1 to 612 | 612/612 (100 %) | 1 diff (99.9 %id) | |||
| BP206802 | coronary artery | .b | 141 to 716 | 1 to 576 | 576/581 (99 %) | 6 diff (99.0 %id) | |||
| BM011688 | brain, neuroblastoma, cell line | .b | 141 to 946 | 1 to 806 | 806/807 (99 %) | 7 diff (99.2 %id) | |||
| TI_59380861 | .b | 141 to 946 | 95 to 900 | 806/807 (99 %) | 7 diff (99.2 %id) | ||||
| BM721122 | eye, fetal eye | .b | 141 to 837 | 1 to 697 | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 697/697 (100 %) | 1 diff (99.9 %id) | ||
| BM887934 | eye | .b | 146 to 664 | 1 to 528 | 528/544 (97 %) | 10 diff (98.2 %id) | |||
| CD632791 | .b | 159 to 793 | 1 to 637 | 639/640 (99 %) | 19 diff (97.1 %id) | ||||
| CD632793 | .b | 159 to 799 | 1 to 636 | 636/647 (98 %) | 6 diff (99.1 %id) | ||||
| CD632795 | .b | 159 to 780 | 1 to 626 | 626/628 (99 %) | 13 diff (98.0 %id) | ||||
| BQ932724 | sciatic nerve | .b | 161 to 994 | 1 to 844 | I216M G217E C219G S220G F221X ... | 844/891 (94 %) | 21 diff (97.7 %id) | ||
| BG746105 | Spleen | .b | 802 to 1564 | 798 to 26 | 773/814 (94 %) | 0 diff (100 %id) | |||
| BM679547 | eye, fetal eye | .b | 978 to 1638 | 678 to 18 | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 661/661 (100 %) | 0 diff (100 %id) | |
| AA169752 | .b | 1088 to 1638 | 551 to 1 | 551/552 (99 %) | 9 diff (98.4 %id) | ||||
| DB355367 | whole embryo, mainly head | .b | 1089 to 1638 | 550 to 1 | 550/552 (99 %) | 10 diff (98.2 %id) | |||
| DB376973 | placenta | .b | 1089 to 1638 | 550 to 1 | 550/552 (99 %) | 14 diff (97.5 %id) | |||
| DB358314 | whole embryo, mainly head | .b | 1108 to 1638 | 532 to 1 | 532/549 (96 %) | 16 diff (97.1 %id) | |||
| DB377195 | placenta | .b | 1124 to 1638 | 515 to 1 | 515/517 (99 %) | 4 diff (99.3 %id) | |||
| DB294926 | .b | 1126 to 1638 | 513 to 1 | 513/513 (100 %) | 0 diff (100 %id) | ||||
| DB378076 | placenta | .b | 1136 to 1638 | 502 to 1 | 502/572 (87 %) | 11 diff (98.1 %id) | |||
| DB357789 | whole embryo, mainly head | .b | 1142 to 1638 | 498 to 1 | 498/498 (100 %) | 5 diff (99.0 %id) | |||
| DB374403 | placenta | .b | 1188 to 1638 | 452 to 1 | 452/452 (100 %) | 6 diff (98.7 %id) | |||
| BX428062 | fetal liver, Liver | .b | 1210 to 2055 | 848 to 1 | 848/860 (98 %) | 33 diff (96.2 %id) | |||
| BJ996187 | hepatoblastoma | .b | 1213 to 1602 | 391 to 1 | 391/391 (100 %) | 2 diff (99.5 %id) | |||
| BU950236 | Pancreas, Purified pancreatic islet | .b | 1229 to 1637 | 409 to 1 | 409/409 (100 %) | 1 diff (99.8 %id) | |||
| BU949237 | Pancreas, Purified pancreatic islet | .b | 1324 to 1637 | 314 to 1 | 314/314 (100 %) | 0 diff (100 %id) | |||
| CA389327 | eye, RPE/choroid | .c | 1 to 684 | 1 to 684 | tiling clone, | 684/684 (100 %) | 0 diff (100 %id) | ||
| BX338306 | Placenta Cot 25-normalized | .c | 8 to 930 | 1 to 912 | exact | tiling clone, fully sequenced, | 912/912 (100 %) | 13 diff (98.6 %id) | |
| BX338305 | Placenta Cot 25-normalized | .c | 911 to 1832 | 906 to 1 | tiling clone, fully sequenced, | 906/906 (100 %) | 20 diff (97.8 %id) | ||
| AY640929 | .d | 1 to 2132 | 2 to 2133 | exact | tiling clone, AAA | Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) | 2133/2133 (100 %) | 1 diff (100.0 %id) | |
| BU959761 | mixed (pool of 40 RNAs) | .d | 1169 to 1808 | 1 to 648 | 648/758 (85 %) | 22 diff (97.1 %id) | |||
| DA571511 | whole embryo, mainly head | .d | 1195 to 2022 | 2 to 833 | capped | 832/832 (100 %) | 9 diff (99.0 %id) | ||
| AI983855 | adenocarcinoma, Pancreas | .d | 1201 to 1685 | 487 to 1 | 487/487 (100 %) | 5 diff (99.0 %id) | |||
| AI925556 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .d | 1206 to 1685 | 480 to 1 | 480/480 (100 %) | 0 diff (100 %id) | |||
| BE677197 | dorsal root ganglia | .d | 1220 to 1687 | 469 to 1 | 469/469 (100 %) | 2 diff (99.6 %id) | |||
| AA622018 | colon, colon tumor RER+ | .d | 1233 to 1683 | 450 to 1 | 450/450 (100 %) | 3 diff (99.4 %id) | |||
| AW069481 | bone marrow stroma | .d | 1245 to 1684 | 458 to 19 | AAA | Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) | 440/440 (100 %) | 0 diff (100 %id) | |
| AA826793 | invasive tumor (cell line), Prostate | .d | 1246 to 1684 | 439 to 1 | 439/439 (100 %) | 8 diff (98.2 %id) | |||
| BM310652 | Pancreas, Purified pancreatic islet | .d | 1261 to 1683 | 423 to 1 | 423/423 (100 %) | 0 diff (100 %id) | |||
| AI352114 | .d | 1263 to 1687 | 426 to 1 | 426/426 (100 %) | 3 diff (99.3 %id) | ||||
| BX117068 | liver and spleen | .d | 1266 to 1987 | 1 to 722 | 722/722 (100 %) | 7 diff (99.1 %id) | |||
| BE677196 | dorsal root ganglia | .d | 1266 to 1687 | 423 to 1 | 423/423 (100 %) | 2 diff (99.6 %id) | |||
| AA630606 | .d | 1277 to 1682 | 405 to 1 | 405/405 (100 %) | 13 diff (96.8 %id) | ||||
| N76577 | liver and spleen | .d | 1290 to 1450 | 1 to 162 | 162/162 (100 %) | 3 diff (98.2 %id) | |||
| BF382750 | brain, primitive neuroectoderm | .d | 1296 to 1775 | 1 to 483 | 483/815 (59 %) | 25 diff (97.0 %id) | |||
| TI_154110764 | .d | 1330 to 2131 | 886 to 87 | 800/1033 (77 %) | 0 diff (100 %id) | ||||
| BU930726 | Prostate | .d | 1405 to 1876 | 1 to 478 | 478/1030 (46 %) | 8 diff (99.3 %id) | |||
| AV726728 | hypothalamus | .d | 1507 to 2014 | 16 to 523 | AAA | Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) | 508/523 (97 %) | 6 diff (98.9 %id) | |
| BQ009703 | Chondrosarcoma, Left Pubic Bone | .d | 1525 to 2132 | 626 to 19 | AAA | Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) | 608/608 (100 %) | 0 diff (100 %id) | |
| AW970436 | .d | 1593 to 2037 | 31 to 475 | 445/593 (75 %) | 9 diff (98.5 %id) | ||||
| BX503537 | .d | 1594 to 2134 | 541 to 2 | 540/541 (99 %) | 0 diff (100 %id) | ||||
| CD638897 | pooled | .d | 1606 to 2134 | 18 to 546 | 529/552 (95 %) | 7 diff (98.8 %id) | |||
| BF882969 | lung_tumor | .d | 1628 to 1963 | 336 to 1 | Submitted on the opposite strand | 336/336 (100 %) | 3 diff (99.2 %id) | ||
| BF883778 | lung_tumor | .d | 1628 to 1963 | 337 to 1 | Submitted on the opposite strand | 337/337 (100 %) | 2 diff (99.5 %id) | ||
| BU564969 | mixed (pool of 40 RNAs) | .d | 1654 to 2014 | 1 to 366 | 366/401 (91 %) | 8 diff (98.1 %id) | |||
| AW473802 | poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus | .d | 1661 to 2139 | 480 to 1 | 480/480 (100 %) | 2 diff (99.6 %id) | |||
| AB083072 | thyroid | .d | 1674 to 2128 | 1 to 457 | AAA | Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) | 457/457 (100 %) | 3 diff (99.4 %id) | |
| BF590308 | pooled | .d | 1682 to 2134 | 460 to 7 | 454/460 (98 %) | 0 diff (100 %id) | |||
| N54466 | liver and spleen | .d | 1685 to 2132 | 449 to 1 | 449/450 (99 %) | 5 diff (98.9 %id) | |||
| CA428285 | Bone, Subchondral Bone | .d | 1685 to 2132 | 466 to 19 | AAA | Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) | 448/450 (99 %) | 1 diff (99.8 %id) | |
| AI341115 | pooled germ cell tumors | .d | 1687 to 2134 | 453 to 6 | 448/453 (98 %) | 0 diff (100 %id) | |||
| AW069100 | bone marrow stroma | .d | 1690 to 2132 | 461 to 19 | AAA | Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) | 443/443 (100 %) | 0 diff (100 %id) | |
| DB522041 | testis | .d | 1695 to 2132 | 1 to 438 | AAA | Submitted on the opposite strand | 438/438 (100 %) | 9 diff (98.0 %id) | |
| H02646 | placenta | .d | 1707 to 2133 | 1 to 438 | 438/442 (99 %) | 23 diff (94.8 %id) | |||
| AI167674 | parathyroid gland, parathyroid tumor | .d | 1708 to 2134 | 431 to 6 | 426/431 (98 %) | 0 diff (100 %id) | |||
| CD677707 | eye, Trabecular meshwork | .d | 1709 to 2131 | 1 to 423 | 423/423 (100 %) | 0 diff (100 %id) | |||
| BM090855 | Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) | .d | 1714 to 2014 | 328 to 28 | AAA | Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) | 301/301 (100 %) | 4 diff (98.7 %id) | |
| AI695553 | colon | .d | 1715 to 2139 | 424 to 1 | 424/446 (95 %) | 16 diff (96.5 %id) | |||
| TI_151764692 | .d | 1716 to 2134 | 105 to 523 | 419/1288 (32 %) | 8 diff (99.4 %id) | ||||
| AI335907 | uterus | .d | 1717 to 2132 | 416 to 1 | 416/416 (100 %) | 0 diff (100 %id) | |||
| BE074542 | breast | .d | 1718 to 2007 | 298 to 8 | Submitted on the opposite strand | 291/298 (97 %) | 4 diff (98.7 %id) | ||
| AI377478 | .d | 1718 to 2134 | 419 to 3 | 417/419 (99 %) | 0 diff (100 %id) | ||||
| AA443946 | .d | 1719 to 2134 | 416 to 2 | 415/416 (99 %) | 0 diff (100 %id) | ||||
| AA768408 | germinal center B cell | .d | 1738 to 2132 | 411 to 31 | AAA | Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) | 381/381 (100 %) | 6 diff (98.5 %id) | |
| BU676254 | lung, Primary Lung Epithelial Cells | .d | 1739 to 2014 | 294 to 19 | AAA | Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) | 276/276 (100 %) | 1 diff (99.7 %id) | |
| CN255815 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .d | 1740 to 2005 | 1 to 266 | 266/266 (100 %) | 0 diff (100 %id) | |||
| AI274003 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .d | 1750 to 2134 | 384 to 1 | 384/384 (100 %) | 1 diff (99.8 %id) | |||
| AA431454 | .d | 1758 to 2140 | 390 to 8 | 383/390 (98 %) | 0 diff (100 %id) | ||||
| AA621404 | .d | 1763 to 2134 | 381 to 7 | 375/381 (98 %) | 0 diff (100 %id) | ||||
| BF031441 | hypernephroma, Kidney | .d | 1766 to 2485 | 1 to 706 | 706/801 (88 %) | 37 diff (95.4 %id) | |||
| AA593091 | Prostate, prostatic intraepithelial neoplasia - highgrade | .d | 1773 to 2129 | 364 to 7 | 358/364 (98 %) | 0 diff (100 %id) | |||
| BU674476 | lung, Primary Lung Epithelial Cells | .d | 1780 to 2135 | 371 to 16 | AAA | Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) | 356/356 (100 %) | 6 diff (98.4 %id) | |
| BF727025 | eye, lens | .d | 1781 to 2474 | 1 to 694 | tiling clone, | 694/694 (100 %) | 0 diff (100 %id) | ||
| AA127838 | uterus | .d | 1781 to 2146 | 1 to 368 | 368/371 (99 %) | 8 diff (97.9 %id) | |||
| AA132208 | uterus | .d | 1781 to 2249 | 1 to 471 | 471/471 (100 %) | 2 diff (99.6 %id) | |||
| AA807643 | pooled germ cell tumors | .d | 1845 to 2134 | 295 to 6 | 290/295 (98 %) | 0 diff (100 %id) | |||
| BG527040 | lung, mucoepidermoid carcinoma | .d | 1850 to 2487 | 1 to 641 | 641/741 (86 %) | 20 diff (97.4 %id) | |||
| BF701115 | brain, primitive neuroectoderm | .d | 1851 to 2501 | 1 to 639 | 639/833 (76 %) | 16 diff (98.1 %id) | |||
| BF739818 | Kidney | .d | 1855 to 2140 | 292 to 8 | 285/292 (97 %) | 0 diff (100 %id) | |||
| AA535949 | colon | .d | 1876 to 2015 | 140 to 1 | 140/140 (100 %) | 0 diff (100 %id) | |||
| BU588560 | mixed (pool of 40 RNAs) | .d | 1889 to 2014 | 1 to 126 | AAA | Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) | 126/126 (100 %) | 2 diff (98.5 %id) | |
| DR979277 | placenta | .d | 1913 to 2014 | 1 to 101 | AAA | Submitted on the opposite strand | 101/101 (100 %) | 6 diff (94.1 %id) | |
| BF698579 | brain, primitive neuroectoderm | .d | 1917 to 2432 | 1 to 518 | 518/518 (100 %) | 5 diff (99.1 %id) | |||
| BF211337 | bone marrow, from chronic myelogenous leukemia | .d | 1962 to 2573 | 1 to 621 | 621/698 (88 %) | 32 diff (95.5 %id) | |||
| BY999141 | .d | 1999 to 2134 | 1 to 136 | Submitted on the opposite strand | 136/137 (99 %) | 2 diff (98.6 %id) | |||
| D20477 | .d | 1999 to 2134 | 1 to 137 | Submitted on the opposite strand | 137/138 (99 %) | 2 diff (98.6 %id) | |||
| BF670512 | muscle (skeletal) | .d | 2142 to 2776 | 1 to 633 | 633/865 (73 %) | 61 diff (93.0 %id) | |||
| BX423241 | brain, fetal brain | .d | 2149 to 3230 | 1074 to 1 | 1074/1131 (94 %) | 19 diff (98.4 %id) | |||
| FN057120 | breast carcinoma | .d | 2237 to 2344 | 108 to 1 | Submitted on the opposite strand | 108/108 (100 %) | 0 diff (100 %id) | ||
| CD101836 | Blood vessels - aorta, basilar and artery | .d | 2246 to 2754 | 1 to 522 | 522/858 (60 %) | 24 diff (97.3 %id) | |||
| BG899036 | cartilage | .d | 2273 to 2598 | 86 to 411 | 326/343 (95 %) | 6 diff (98.3 %id) | |||
| BX434530 | brain, fetal brain | .d | 2340 to 3236 | 896 to 1 | tiling clone, | 896/896 (100 %) | 13 diff (98.6 %id) | ||
| BI334004 | cervical carcinoma cell line, cervix | .d | 2402 to 3132 | 1 to 730 | 730/733 (99 %) | 39 diff (94.7 %id) | |||
| BX434142 | placenta | .d | 2459 to 3223 | 778 to 1 | 778/898 (86 %) | 41 diff (95.5 %id) | |||
| TI_149282330 | .d | 2478 to 3240 | 882 to 124 | AAA | Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) | 759/1035 (73 %) | 9 diff (99.2 %id) | ||
| BG149717 | carcinoid, lung | .d | 2490 to 2885 | 1 to 397 | Submitted on the opposite strand | 397/397 (100 %) | 2 diff (99.5 %id) | ||
| BF110249 | carcinoid, lung | .d | 2490 to 2963 | 1 to 474 | Submitted on the opposite strand | 474/474 (100 %) | 1 diff (99.8 %id) | ||
| AA040621 | uterus | .d | 2494 to 2895 | 1 to 404 | Submitted on the opposite strand | 404/405 (99 %) | 3 diff (99.3 %id) | ||
| BE551124 | carcinoid, lung | .d | 2494 to 2756 | 1 to 263 | Submitted on the opposite strand | 263/263 (100 %) | 4 diff (98.5 %id) | ||
| R64534 | placenta | .d | 2520 to 2890 | 1 to 374 | 374/377 (99 %) | 5 diff (98.7 %id) | |||
| BG548348 | lung | .d | 2520 to 3144 | 1 to 626 | 626/626 (100 %) | 5 diff (99.3 %id) | |||
| FN074533 | breast carcinoma | .d | 2547 to 2648 | 1 to 97 | 97/108 (89 %) | 8 diff (92.6 %id) | |||
| BU165730 | testis | .d | 2574 to 3239 | 1 to 669 | 669/806 (83 %) | 9 diff (98.9 %id) | |||
| FN147891 | breast carcinoma | .d | 2576 to 2690 | 111 to 1 | Submitted on the opposite strand | 111/118 (94 %) | 3 diff (97.5 %id) | ||
| BG925715 | cartilage | .d | 2578 to 3213 | 81 to 716 | 636/648 (98 %) | 6 diff (99.1 %id) | |||
| BM983766 | lung, Primary Lung Epithelial Cells | .d | 2586 to 3240 | 672 to 19 | AAA | Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) | 654/654 (100 %) | 4 diff (99.4 %id) | |
| FN135404 | breast carcinoma | .d | 2617 to 2696 | 79 to 1 | Submitted on the opposite strand | 79/79 (100 %) | 1 diff (98.8 %id) | ||
| FN054325 | breast carcinoma | .d | 2657 to 2798 | 1 to 142 | 142/142 (100 %) | 0 diff (100 %id) | |||
| DB358372 | whole embryo, mainly head | .d | 2661 to 3238 | 574 to 3 | 572/574 (99 %) | 0 diff (100 %id) | |||
| BX418370 | brain, fetal brain | .d | 2679 to 3209 | 537 to 1 | 909/939 (96 %) | 43 diff (95.5 %id) | |||
| AW977767 | .d | 2688 to 3239 | 552 to 1 | Submitted on the opposite strand | 552/552 (100 %) | 7 diff (98.8 %id) | |||
| DB552784 | hippocampus | .d | 2761 to 3238 | 1 to 478 | Submitted on the opposite strand | 478/480 (99 %) | 2 diff (99.6 %id) | ||
| N40203 | multiple sclerosis lesions | .d | 2776 to 3240 | 475 to 1 | 475/481 (98 %) | 15 diff (96.9 %id) | |||
| FN141794 | breast carcinoma | .d | 2796 to 2918 | 125 to 2 | Submitted on the opposite strand | 124/126 (98 %) | 0 diff (100 %id) | ||
| AA811265 | germinal center B cell | .d | 2799 to 3247 | 460 to 12 | tiling clone, AAA | Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) | 449/449 (100 %) | 0 diff (100 %id) | |
| AI582161 | lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) | .d | 2805 to 3240 | 455 to 20 | AAA | Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) | 436/436 (100 %) | 1 diff (99.8 %id) | |
| AA040620 | uterus | .d | 2831 to 3240 | 463 to 52 | AAA | Submitted on the opposite strand | 412/412 (100 %) | 2 diff (99.6 %id) | |
| AA132065 | uterus | .d | 2836 to 3240 | 408 to 1 | 408/437 (93 %) | 5 diff (98.9 %id) | |||
| FN073174 | breast carcinoma | .d | 2842 to 2945 | 101 to 1 | Submitted on the opposite strand | 101/102 (99 %) | 3 diff (97.1 %id) | ||
| AW001618 | Kidney | .d | 2847 to 3245 | 402 to 3 | 400/402 (99 %) | 0 diff (100 %id) | |||
| DB536554 | hippocampus | .d | 2850 to 3240 | 19 to 411 | Submitted on the opposite strand | 393/411 (95 %) | 14 diff (96.6 %id) | ||
| AI222332 | pooled | .d | 2866 to 3247 | 382 to 1 | 382/382 (100 %) | 1 diff (99.8 %id) | |||
| AI796277 | Kidney | .d | 2871 to 3242 | 370 to 1 | 370/370 (100 %) | 2 diff (99.5 %id) | |||
| FN152265 | breast carcinoma | .d | 2887 to 2985 | 97 to 1 | Submitted on the opposite strand | 97/98 (98 %) | 2 diff (98.0 %id) | ||
| BQ024390 | placenta | .d | 2896 to 3240 | 363 to 19 | AAA | Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) | 345/345 (100 %) | 0 diff (100 %id) | |
| AW886032 | ovary | .d | 2913 to 3148 | 244 to 9 | 236/291 (81 %) | 0 diff (100 %id) | |||
| C21544 | .d | 2948 to 3240 | 1 to 293 | 293/293 (100 %) | 0 diff (100 %id) | ||||
| AI626127 | colon | .d | 3035 to 3240 | 225 to 20 | AAA | Possibly primed on the genome, locally A rich (14/16 A in genome downstream of last aligned base) | 206/206 (100 %) | 5 diff (97.6 %id) | |
| AW019878. matches multiple genes | cochlea, ear | .d | 3064 to 3245 | 1 to 182 | also hits gene GCFC1 | 182/184 (98 %) | 6 diff (96.8 %id) | ||
| Z25204 | leg muscle, skeletal muscle | .d | 3066 to 3239 | 1 to 174 | 174/174 (100 %) | 2 diff (98.9 %id) | |||
| DB185090 | liver, tumor tissue | .e | 1 to 568 | 2 to 570 | tiling clone, capped | 569/569 (100 %) | 1 diff (99.9 %id) | ||
| CA772577 | Pancreas, Purified pancreatic islet | .e | 5 to 784 | 1 to 780 | exact | tiling clone, fully sequenced, AAA | Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) | 780/780 (100 %) | 5 diff (99.4 %id) |
| BQ269248 | Pancreas, Purified pancreatic islet | .e | 63 to 565 | 1 to 503 | fully sequenced, | 503/503 (100 %) | 4 diff (99.3 %id) | ||
| DB162141 | thymus | .e | 76 to 655 | 2 to 581 | exact | capped | 580/580 (100 %) | 0 diff (100 %id) | |
| CA771736 | Pancreas, Purified pancreatic islet | .e | 204 to 789 | 591 to 5 | fully sequenced, | Possibly primed on the genome, locally A rich (16/17 A in genome downstream of last aligned base) | 587/591 (99 %) | 0 diff (100 %id) | |
| AI418308 | pooled | .e | 318 to 782 | 465 to 1 | 465/465 (100 %) | 5 diff (99.0 %id) | |||
| AA654812 | .e | 370 to 702 | 1 to 333 | 333/333 (100 %) | 2 diff (99.4 %id) | ||||
| BQ285890 | Pancreas, Purified pancreatic islet | .e | 535 to 791 | 257 to 1 | fully sequenced, | 257/257 (100 %) | 0 diff (100 %id) | ||
| DA006700 | .f | 1 to 572 | 2 to 574 | D10G Y12L Q13P T14D S15K ... | tiling clone, capped | 573/573 (100 %) | 1 diff (99.9 %id) | ||
| BP310538 | brain | .g | 1 to 588 | 1 to 588 | tiling clone, | 588/588 (100 %) | 0 diff (100 %id) | ||
| BF213417 | bone marrow, from acute myelogenous leukemia | .g | 61 to 657 | 1 to 590 | L73W A74Q G75V P76Q M77W ... | 590/875 (67 %) | 20 diff (97.8 %id) | ||
| BP276169 | Kidney | .g | 66 to 615 | 1 to 549 | 549/581 (94 %) | 6 diff (99.0 %id) | |||
| DB193770 | ovary, tumor tissue | .g | 66 to 626 | 2 to 563 | capped | 562/562 (100 %) | 2 diff (99.7 %id) | ||
| DB208282 | trachea | .g | 79 to 616 | 2 to 540 | capped | 539/546 (98 %) | 2 diff (99.7 %id) | ||
| DA424520 | .g | 84 to 653 | 2 to 571 | tiling clone, capped | 570/570 (100 %) | 1 diff (99.9 %id) | |||
| AK307251 | Gene YIPF5, variant not shown | Suspected internal deletion, this clone was ignored | |||||||
| AY640934 | Gene YIPF5, variant not shown | AAA | Suspected internal deletion, this clone was ignored | ||||||
| CD695794 | normal nasopharynx | Gene YIPF5, variant not shown | Suspected internal deletion, this clone was ignored | ||||||
| AV714350 | Gene YIPF5, variant not shown | This clone was ignored | |||||||
| AV713741 | Gene YIPF5, variant not shown | This clone was ignored | |||||||
| AV661198 | corresponding non cancerous liver tissue | Gene YIPF5, variant not shown | Submitted on the opposite strand | ||||||
| CD678669 | eye, Trabecular meshwork | Gene YIPF5, variant not shown | Suspected internal deletion, this clone was ignored | ||||||
| BF965857 | Bone, osteosarcoma, cell line | Gene YIPF5, variant not shown | Suspected internal deletion, this clone was ignored | ||||||
| DB321707 | Gene YIPF5, variant not shown | This clone was ignored | |||||||
| DA651493 | Gene YIPF5, variant not shown | capped | This clone was ignored | ||||||
| BP307272 | brain | Gene YIPF5, variant not shown | Suspected internal deletion, this clone was ignored | ||||||
| BP307530 | brain | Gene YIPF5, variant not shown | Suspected internal deletion, this clone was ignored | ||||||
| DC424156 | Gene YIPF5, variant not shown | Suspected internal deletion, this clone was ignored |
| ? | Gene Summary | Gene on genome | mRNA:.a, .b, .c, .d, .e, .f, .g | Alternative mRNAs features, proteins, introns, exons, sequences | Expression Tissue | Function, regulation, related genes CI |